Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Anatomy (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Biological Phenomena, Cell Phenomena, and Immunity (1)
- Biology (1)
-
- Cell Biology (1)
- Cell and Developmental Biology (1)
- Cells (1)
- Cognitive Neuroscience (1)
- Disease Modeling (1)
- Immune System Diseases (1)
- Immunology and Infectious Disease (1)
- Immunopathology (1)
- Laboratory and Basic Science Research (1)
- Medical Cell Biology (1)
- Medical Immunology (1)
- Medical Microbiology (1)
- Medical Molecular Biology (1)
- Medical Pharmacology (1)
- Medical Specialties (1)
- Microbiology (1)
Articles 1 - 2 of 2
Full-Text Articles in Medical Neurobiology
The Current Neuroscientific Understanding Of Alzheimer's Disease, Rachel A. Brandes
The Current Neuroscientific Understanding Of Alzheimer's Disease, Rachel A. Brandes
Pursuit - The Journal of Undergraduate Research at The University of Tennessee
Alzheimer’s disease is a degenerative neurological illness characterized by the deterioration of brain regions implicated in memory and cognitive function. While researchers have yet to find a cure or effective treatment, they have gained a better understanding of its pathology and development. Through years of neuroscience research, scientists have discovered much of what happens in the brain during Alzheimer’s disease onset and how this causes its symptoms; many hypotheses regarding this aspect of the illness involve temporal lobe atrophy, neurofibrillary tangles, and amyloid plaques. Although Alzheimer’s disease affects millions of people every day, it seems that most are unaware of …
Fty720 (Fingolimod) Provides Insight Into The Molecular Mechanisms Of Multiple Sclerosis, Madelyn Elizabeth Crawford
Fty720 (Fingolimod) Provides Insight Into The Molecular Mechanisms Of Multiple Sclerosis, Madelyn Elizabeth Crawford
Pursuit - The Journal of Undergraduate Research at The University of Tennessee
Multiple sclerosis (MS) is a neurodegenerative disorder caused by a prolonged immune- mediated inflammatory response that targets myelin. Nearly all of the drugs approved for the treatment of MS are general immunosuppressants or only function in symptom management. The oral medication fingolimod, however, is reported to have direct therapeutic effects on cells of the central nervous system in addition to immunomodulatory functions. Fingolimod is known to interact with sphingosine-1-phosphate (S1P) receptors, and the most widely- accepted theory for its mechanism of action is functional antagonism of the receptor. This review examines significant neuromodulatory effects achieved by functional antagonism of the …